Share on StockTwits

Lannett Company (NYSE:LCI) shares hit a new 52-week high on Wednesday , Analyst RN reports. The company traded as high as $51.59 and last traded at $51.38, with a volume of 165,439 shares trading hands. The stock had previously closed at $49.96.

LCI has been the subject of a number of recent research reports. Analysts at Canaccord Genuity initiated coverage on shares of Lannett Company in a research note on Tuesday, May 6th. They set a “buy” rating and a $55.00 price target on the stock. Analysts at Zacks downgraded shares of Lannett Company from an “outperform” rating to a “neutral” rating in a research note on Wednesday, April 9th. They now have a $37.80 price target on the stock. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Lannett Company currently has a consensus rating of “Buy” and a consensus target price of $42.95.

The stock has a 50-day moving average of $43.96 and a 200-day moving average of $38.56. The company has a market cap of $1.821 billion and a P/E ratio of 44.93.

Lannett Company (NYSE:LCI) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.60 by $0.03. The company had revenue of $80.00 million for the quarter, compared to the consensus estimate of $84.50 million. During the same quarter in the prior year, the company posted $0.14 earnings per share. The company’s quarterly revenue was up 105.0% on a year-over-year basis. Analysts expect that Lannett Company will post $1.75 EPS for the current fiscal year.

In other Lannett Company news, major shareholder David Farber sold 7,500 shares of the stock on the open market in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $50.00, for a total transaction of $375,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Lannett Company, Inc is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.